Literature DB >> 31992118

Mouse models of hemostasis.

Bassem M Mohammed1,2, Dougald M Monroe3, David Gailani1.   

Abstract

Hemostasis is the normal process that produces a blood clot at a site of vascular injury. Mice are widely used to study hemostasis and abnormalities of blood coagulation because their hemostatic system is similar in most respects to that of humans, and their genomes can be easily manipulated to create models of inherited human coagulation disorders. Two of the most widely used techniques for assessing hemostasis in mice are the tail bleeding time (TBT) and saphenous vein bleeding (SVB) models. Here we discuss the use of these methods in the evaluation of hemostasis, and the advantages and limits of using mice as surrogates for studying hemostasis in humans.

Entities:  

Keywords:  Bleeding; hemostasis; mouse models

Mesh:

Year:  2020        PMID: 31992118      PMCID: PMC7244364          DOI: 10.1080/09537104.2020.1719056

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  86 in total

Review 1.  A guide to murine coagulation factor structure, function, assays, and genetic alterations.

Authors:  J J Emeis; M Jirouskova; E-M Muchitsch; A S Shet; S S Smyth; G J Johnson
Journal:  J Thromb Haemost       Date:  2007-04       Impact factor: 5.824

Review 2.  A guide to murine platelet structure, function, assays, and genetic alterations.

Authors:  M Jirouskova; A S Shet; G J Johnson
Journal:  J Thromb Haemost       Date:  2007-04       Impact factor: 5.824

3.  Congenital factor XI deficiency in a domestic shorthair cat.

Authors:  Mark T Troxel; Marjory B Brooks; Meredith L Esterline
Journal:  J Am Anim Hosp Assoc       Date:  2002 Nov-Dec       Impact factor: 1.023

4.  Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.

Authors:  L Bi; A M Lawler; S E Antonarakis; K A High; J D Gearhart; H H Kazazian
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

5.  Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment.

Authors:  Helen V Yarovoi; Dubravka Kufrin; Don E Eslin; Michael A Thornton; Sandra L Haberichter; Qizhen Shi; Hua Zhu; Rodney Camire; Steve S Fakharzadeh; M Anna Kowalska; David A Wilcox; Bruce S Sachais; Robert R Montgomery; Mortimer Poncz
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

6.  Prolonged effect of a new O-glycoPEGylated FVIII (N8-GP) in a murine saphenous vein bleeding model.

Authors:  A E Pastoft; M Ezban; M Tranholm; J Lykkesfeldt; B Lauritzen
Journal:  Haemophilia       Date:  2013-06-04       Impact factor: 4.287

7.  Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice.

Authors:  Maureen A Shaw; Keith W Kombrinck; Kathryn E McElhinney; David R Sweet; Matthew J Flick; Joseph S Palumbo; Mei Cheng; Naomi L Esmon; Charles T Esmon; Alexander Brill; Denisa D Wagner; Jay L Degen; Eric S Mullins
Journal:  Blood       Date:  2016-06-01       Impact factor: 22.113

8.  A canine model of hemophilic (factor VIII:C deficiency) bleeding.

Authors:  A R Giles; S Tinlin; R Greenwood
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

9.  New approaches in tail-bleeding assay in mice: improving an important method for designing new anti-thrombotic agents.

Authors:  Max Seidy Saito; André Luiz Lourenço; Hye Chung Kang; Carlos Rangel Rodrigues; Lucio Mendes Cabral; Helena Carla Castro; Plínio Cunha Satlher
Journal:  Int J Exp Pathol       Date:  2016-07-05       Impact factor: 1.925

10.  A non-circulating pool of factor XI associated with glycosaminoglycans in mice.

Authors:  Bassem M Mohammed; Qiufang Cheng; Anton Matafonov; Ingrid M Verhamme; Jonas Emsley; Keith R McCrae; Owen J T McCarty; Andras Gruber; David Gailani
Journal:  J Thromb Haemost       Date:  2019-06-17       Impact factor: 16.036

View more
  5 in total

1.  Murine Models in the Evaluation of Heparan Sulfate-Based Anticoagulants.

Authors:  Bassem M Mohammed; Qiufang Cheng; Ivan S Ivanov; David Gailani
Journal:  Methods Mol Biol       Date:  2022

2.  A Common Missense Variant Causing Factor XI Deficiency and Increased Bleeding Tendency in Maine Coon Cats.

Authors:  Henrike Kuder; S Kent Dickeson; Marjory B Brooks; Alexandra Kehl; Elisabeth Müller; David Gailani; Urs Giger
Journal:  Genes (Basel)       Date:  2022-04-28       Impact factor: 4.141

3.  Murine cadherin-6 mediates thrombosis in vivo in a platelet-independent manner.

Authors:  Emma G Bouck; Maria de la Fuente; Elizabeth R Zunica; Wei Li; Michele M Mumaw; Marvin T Nieman
Journal:  Res Pract Thromb Haemost       Date:  2020-12-04

4.  Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.

Authors:  Cho Yeow Koh; Norrapat Shih; Christina Y C Yip; Aaron Wei Liang Li; Weiming Chen; Fathiah S Amran; Esther Jia En Leong; Janaki Krishnamoorthy Iyer; Grace Croft; Muhammad Ibrahim Bin Mazlan; Yen-Lin Chee; Eng-Soo Yap; Dougald M Monroe; Maureane Hoffman; Richard C Becker; Dominique P V de Kleijn; Vaishali Verma; Amita Gupta; Vijay K Chaudhary; A Mark Richards; R Manjunatha Kini; Mark Y Chan
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

5.  Methods to Investigate miRNA Function: Focus on Platelet Reactivity.

Authors:  Alix Garcia; Sylvie Dunoyer-Geindre; Richard J Fish; Marguerite Neerman-Arbez; Jean-Luc Reny; Pierre Fontana
Journal:  Thromb Haemost       Date:  2020-10-29       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.